Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-062527

Chief Executive Officer sold 7,800 shares at an average $42.66 ($332,709)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-12-12 Sale −3,900 $42.56 $165,984 23,578 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-12-13 Sale −3,900 $42.75 $166,725 19,678 I: show line 2 in the form
Open-market sales · 7,800 sh · avg $42.66 · $332,709
Loading xslF345X03/doc4.xml…